Patents by Inventor Rafi Ahmed

Rafi Ahmed has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20120282273
    Abstract: Antibodies that bind with high affinity to swine H1N1 virus are described. In vivo experiments showed that one such antibody is able to fully protect mice challenged with a lethal dose of swine H1N1 virus. The antibody is also able to cure mice in a therapeutic setting when treated as late as up to 60 hours (2.5 days) after infection with swine H1N1 virus. Also described are recombinant forms of this antibody.
    Type: Application
    Filed: October 12, 2010
    Publication date: November 8, 2012
    Inventors: Jens Wrammert, Rafi Ahmed, Patrick Wilson
  • Publication number: 20120251537
    Abstract: PD-1 antagonists are disclosed that can be used to reduce the expression or activity of PD-1 in a subject. An immune response specific to an infectious agent or to tumor cells can be enhanced using these PD-1 antagonists in conjunction with an antigen from the infectious agent or tumor. Thus, subjects with infections, such as persistent infections can be treated using PD-1 antagonists. In addition, subjects with tumors can be treated using the PD-1 antagonists. In several examples, subjects can be treated by transplanting a therapeutically effective amount of activated T cells that recognize an antigen of interest and by administering a therapeutically effective amount of a PD-1 antagonist.
    Type: Application
    Filed: March 30, 2012
    Publication date: October 4, 2012
    Inventors: Rafi Ahmed, Rama Amara, Gordon Freeman, Arlene Sharpe
  • Patent number: 8209322
    Abstract: Techniques for optimizing queries are provided. In one technique, a query optimizer determines that two tables involved in equi-joins with one other table return unique rows. The query optimizer further determines that the rows returned by one of the tables is a subset of the rows returned by the other table. The query optimizer then determines that one of the two tables involved in the equi-joins can be eliminated. In another technique, a query optimizer determines that group-by placement may be used on a query that specifies a table. The query optimizer further determines that a view that (1) replaces the table and (2) results from the group-by placement is a subset of an existing view. The query optimizer further determines that each view is unique. The query optimizer selects an execution plan that does not join any tables or views with the resulting view or with the specified table.
    Type: Grant
    Filed: August 21, 2007
    Date of Patent: June 26, 2012
    Assignee: Oracle International Corporation
    Inventor: Rafi Ahmed
  • Patent number: 8150865
    Abstract: Methods for transforming queries that contain EXISTS and NOT EXISTS subqueries are provided. The methods provided transform original queries that contain EXISTS and/or NOT EXISTS subqueries in conjunctive or disjunctive combinations into transformed queries that coalesce the original EXISTS and/or NOT EXISTS subqueries into a reduced number of EXISTS and/or NOT EXISTS subqueries, thereby eliminating duplicative table accesses and join operations.
    Type: Grant
    Filed: July 29, 2008
    Date of Patent: April 3, 2012
    Assignee: Oracle International Corporation
    Inventors: Rafi Ahmed, Srikanth Bellamkonda
  • Publication number: 20110271358
    Abstract: The present invention is based, in part, on the identification of novel human anti-PD-1, PD-L1, and PD-L2 antibodies. Accordingly, the invention relates to compositions and methods for diagnosing, prognosing, and treating conditions that would benefit from modulating PD-1, PD-L1, and/or PD-L2 activity (e.g., persistent infectious diseases, autoimmune diseases, asthma, transplant rejection, inflammatory disorders and tumors) using the novel human anti-PD-1, PD-L1, and PD-L2 antibodies described herein.
    Type: Application
    Filed: September 25, 2009
    Publication date: November 3, 2011
    Applicant: Dana-Farber Cancer Institute, Inc.
    Inventors: Gordon J. Freeman, Rafi Ahmed, Timothy D. Jones, Francis J. Carr, James P. Gregson
  • Publication number: 20110129496
    Abstract: It is disclosed herein that treatment of a subject with an mTOR inhibitor enhances antigen-specific T cell immune responses. Thus, provided herein is a method of enhancing an antigen-specific T cell response in a subject by administering to the subject a therapeutically effective amount of an mTOR inhibitor. The antigen can be any antigen, such as an antigen from a pathogen or a vaccine, or a tumor antigen. In some embodiments, the method further comprises administering to the subject a vaccine, such as a virus vaccine or a cancer vaccine. The mTOR inhibitor can be administered either before or after vaccination to enhance the quantity and quality of the T cell immune response and immunological memory. In some examples, the mTOR inhibitor is rapamycin or a rapamycin analog.
    Type: Application
    Filed: August 5, 2009
    Publication date: June 2, 2011
    Applicant: EMORY UNIVERSITY
    Inventors: Rafi Ahmed, Christian P. Larsen, Koichi Araki
  • Patent number: 7945560
    Abstract: Methods for transforming a query to remove redundant subqueries in HAVING clauses are provided. The methods provided transform queries that contain subqueries in HAVING clauses with tables and join conditions and filter conditions equal to tables, join conditions and filter conditions in outer query to queries that eliminate the original subquery and retain the original outer query with a single inline view using window functions. Whether this transformation can be performed depends on which tables and join and filter conditions are in the outer query and the subquery. The transformation eliminates duplicative table accesses and join operations from queries.
    Type: Grant
    Filed: May 22, 2008
    Date of Patent: May 17, 2011
    Assignee: Oracle International Corporation
    Inventors: Rafi Ahmed, Srikanth Bellamkonda
  • Patent number: 7945562
    Abstract: Join predicate push down transformations push down a join predicate of an outer query into a view. Among the types of views for which join predicate push down is performed are a view with a GROUP BY or DISTINCT operator, an anti-joined or semi-joined view, and a view that contains one or more nested views. During optimization, join predicate push down may be used to generate many transformed queries for comparison. The number of query transformations performed for comparison is managed.
    Type: Grant
    Filed: March 8, 2007
    Date of Patent: May 17, 2011
    Assignee: Oracle International Corporation
    Inventors: Rafi Ahmed, Allison Lee, Dinesh Das
  • Publication number: 20110105343
    Abstract: A major challenge in vaccinology is to prospectively determine vaccine efficacy. Disclosed herein are methods and compositions for identifying early expression “signatures” that predicted immune responses in humans vaccinated with a vaccine.
    Type: Application
    Filed: November 23, 2009
    Publication date: May 5, 2011
    Applicant: EMORY UNIVERSITY
    Inventors: Bali Puledran, Rafi Ahmed, Eva Lee, Troy Querec
  • Patent number: 7877379
    Abstract: Techniques are provided for delaying evaluation of expensive expressions in a query. Expensive expressions in the query are established by cost information or by looking up a list of known expensive expressions for a match. After an execution plan is determined by using the early evaluation technique, one or more equivalent execution plans is established. The one or more equivalent execution plans may include both a type of execution plans that delay evaluation of expensive expressions and a type of execution plans that do not. In addition, the one or more equivalent execution plans may include both parallelized and non-parallelized alternatives to the execution plan identified by the early evaluation technique. Finally, based on a set of criteria, which may include comparing cost information among all the equivalent execution plans generated thus far, the best execution plan is chosen for the query.
    Type: Grant
    Filed: September 30, 2005
    Date of Patent: January 25, 2011
    Assignee: Oracle International Corporation
    Inventors: Allison Waingold, Rafi Ahmed, Bhaskar Ghosh, Dinesh Das, Mohamed Zait
  • Publication number: 20100279352
    Abstract: High efficient methods for producing an antibody molecule that binds an antigen are described. The methods include obtaining a population of PBMC enriched for CD19highCD3negCD20low to negCD38highCD27high cells from a mammal exposed to an antigen from sample of cells enriched for PBMC. The cells are isolated from a sample obtained at a time that the fraction of PBMC expressing antibody reactive to the antigen is at a high level. Sequences encoding heavy and light chain variable domains are prepared in a manner that allow production of molecules with natural heavy and light chain pairing.
    Type: Application
    Filed: April 30, 2009
    Publication date: November 4, 2010
    Inventors: Rafi Ahmed, Joseph Miller, Patrick Wilson, Jens Wrammert
  • Patent number: 7814042
    Abstract: In an example embodiment, multiple candidate selection techniques are made available to a query-processing unit for processing a query. A candidate selection technique is chosen from among the available candidate selection techniques for an incoming query. The candidate selection technique may be chosen based on a configuration file or user input or based on some aspect of the query, the user, or the database on which the query will run. A set of semantically equivalent queries (also called a set of candidate queries) is determined for an the incoming query based on the chosen candidate selection technique. A choice is then made among the candidate queries, usually based on a cost measure, as to which query to execute or store for later execution.
    Type: Grant
    Filed: August 17, 2004
    Date of Patent: October 12, 2010
    Assignee: Oracle International Corporation
    Inventor: Rafi Ahmed
  • Patent number: 7814091
    Abstract: Various techniques are described for processing database commands that include MINUS and/or INTERSECT operators. The queries containing the MINUS and/or INTERSECT operators are transformed to create a plurality of transformed queries. Each of the transformed queries produces the same result as the original query, but does not include the MINUS and/or INTERSECT operator. To achieve the same result set as the original query, the transformed queries employ equijoins, antijoins, and/or semijoins, and duplicate elimination operations. Costs are estimated for each of the various transformed queries. Based on the cost estimates, one of the transformed queries is selected as the query that is to be executed to perform the operations specified in the original query.
    Type: Grant
    Filed: September 27, 2005
    Date of Patent: October 12, 2010
    Assignee: Oracle International Corporation
    Inventors: Bhaskar Ghosh, Rafi Ahmed, Hermann Baer
  • Patent number: 7809713
    Abstract: Under a type of query transformation referred to herein as join factorization, the branches of an UNION/UNION ALL query that join a common table are combined to reduce accesses to the common table. The transformation can be expressed as (T1 join T2) union all (T1 join T3)=T1 join (T2 union all T3), where T1, T2 and T3 are three tables. A given query may be rewritten in many alternate ways using join factorization. Evaluating each alternative can be expensive. Therefore, the alternatives are generated and evaluated in a way that minimizes the cost of evaluating the alternatives.
    Type: Grant
    Filed: March 8, 2007
    Date of Patent: October 5, 2010
    Assignee: Oracle International Corporation
    Inventors: Hong Su, Rafi Ahmed, Allison Lee, Mohamed Zait
  • Publication number: 20100151492
    Abstract: PD-1 antagonists are disclosed that can be used to reduce the expression or activity of PD-1 in a subject. An immune response specific to an infectious agent or to tumor cells can be enhanced using these PD-1 antagonists in conjunction with an antigen from the infectious agent or tumor. Thus, subjects with infections, such as persistent infections can be treated using PD-1 antagonists. In addition, subjects with tumors can be treated using the PD-1 antagonists. In several examples, subjects can be treated by transplanting a therapeutically effective amount of activated T cells that recognize an antigen of interest and by administering a therapeutically effective amount of a PD-1 antagonist. Methods are also disclosed for determining the efficacy of a PD-1 antagonist in a subject administered the PD-1 antagonist. In some embodiments, these methods include measuring proliferation of memory B cells in a sample from a subject administered the PD-1 antagonist.
    Type: Application
    Filed: November 27, 2009
    Publication date: June 17, 2010
    Inventors: Rafi Ahmed, Rama Amara, Vijayakumar Velu, Kehmia Titanji, Gordon Freeman
  • Patent number: 7702627
    Abstract: During query optimization, when a particular type of transformation is considered, the effect of performing one or more subsequent kinds of transformations is also considered in conjunction with the first. When applying a transformation, which forecloses applying another, both are considered independently.
    Type: Grant
    Filed: March 8, 2007
    Date of Patent: April 20, 2010
    Assignee: Oracle International Corporation
    Inventors: Rafi Ahmed, Allison Lee
  • Patent number: 7676450
    Abstract: Techniques for performing a “null-aware” anti-join operation are described. Unnesting using anti-join of NOT IN/ALL subquery uses null-aware anti-join operation, resulting in a rewritten query that, when computed, produces results consistent with the NULL semantics of NOT IN/ALL subquery. The semantics of the “null-aware” anti-join operation allow the query having the NOT IN/ALL subquery to be rewritten even though a no-NULL restriction requirement, for the operands of the anti-join condition in the query, may not be met.
    Type: Grant
    Filed: March 8, 2007
    Date of Patent: March 9, 2010
    Assignee: Oracle International Corporation
    Inventors: Rafi Ahmed, Angela Amor
  • Publication number: 20100040614
    Abstract: PD-1 antagonists are disclosed that can be used to reduce the expression or activity of PD-1 in a subject. An immune response specific to an infectious agent or to tumor cells can be enhanced using these PD-1 antagonists in conjunction with an antigen from the infectious agent or tumor. Thus, subjects with infections, such as persistent infections can be treated using PD-1 antagonists. In addition, subjects with tumors can be treated using the PD-1 antagonists. In several examples, subjects can be treated by transplanting a therapeutically effective amount of activated T cells that recognize an antigen of interest and by administering a therapeutically effective amount of a PD-1 antagonist.
    Type: Application
    Filed: December 26, 2007
    Publication date: February 18, 2010
    Inventors: Rafi Ahmed, Rama Amara, Gordon Freeman, Arlene Sharpe
  • Publication number: 20100030756
    Abstract: Methods for transforming queries that contain EXISTS and NOT EXISTS subqueries are provided. The methods provided transform original queries that contain EXISTS and/or NOT EXISTS subqueries in conjunctive or disjunctive combinations into transformed queries that coalesce the original EXISTS and/or NOT EXISTS subqueries into a reduced number of EXISTS and/or NOT EXISTS subqueries, thereby eliminating duplicative table accesses and join operations.
    Type: Application
    Filed: July 29, 2008
    Publication date: February 4, 2010
    Inventors: Rafi Ahmed, Srikanth Bellamkonda
  • Patent number: 7644062
    Abstract: Under a type of query transformation referred to herein as join factorization, the branches of an UNION/UNION ALL query that join a common table are combined to reduce accesses to the common table. The transformation can be expressed as (T1 join T2) union all (T1 join T3)=T1 join (T2 union all T3), where T1, T2 and T3 are three tables. A given query may be rewritten in many alternate ways using join factorization. Evaluating each alternative can be expensive. Therefore, the alternatives are generated and evaluated in a way that minimizes the cost of evaluating the alternatives.
    Type: Grant
    Filed: March 8, 2007
    Date of Patent: January 5, 2010
    Assignee: Oracle International Corporation
    Inventors: Hong Su, Rafi Ahmed, Allison Lee, Mohamed Zait, Thierry Cruanes